Print Page  |  Close Window

SEC Filings

8-K
CHROMADEX CORP. filed this Form 8-K on 03/07/2019
Entire Document
 
 
 
ChromaDex Corporation and Subsidiaries
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated Statements of Operations
 
 
 
 
 
 
Three Months Ended December 31, 2018 and December 30, 2017
 
 
 
(In thousands, except per share data)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Q4 2018 
  Q4 2017 
 
    
    
Sales, net
 $9,067 
 $7,531 
Cost of sales
  4,356 
  3,696 
 
    
    
Gross profit
  4,711 
  3,835 
 
    
    
Operating expenses:
    
    
Sales and marketing
  4,658 
  2,401 
Research and development
  1,275 
  1,453 
General and administrative
  6,943 
  8,759 
Other
  75 
  - 
Operating expenses
  12,951 
  12,613 
 
    
    
Operating loss
  (8,240)
  (8,778)
 
    
    
Nonoperating income (expense):
    
    
Interest income (expense), net
  22 
  (44)
Nonoperating income (expenses)
  22 
  (44)
 
    
    
Net loss
 $(8,218)
 $(8,822)
 
    
    
Basic and diluted loss per common share
 $(0.15)
 $(0.17)
 
    
    
Basic and diluted weighted average common shares outstanding
  55,203 
  51,179 
 

See Notes to Consolidated Financial Statements in Part II of ChromaDex's Annual Report on Form 10-K filed with Securities and Exchange Commission on March 7, 2019.
 
 
 
-5-